APA
Gangat N., Marinaccio C., Swords R., Watts J. M., Gurbuxani S., Rademaker A., Fought A. J., Frankfurt O., Altman J. K., Wen Q. J., Farnoud N., Famulare C. A., Patel A., Tapia R., Vallapureddy R. R., Barath S., Graf A., Handlogten A., Zblewski D., Patnaik M. M., Al-Kali A., Dinh Y. T., Englund Prahl K., Patel S., Nobrega J. C., Tejera D., Thomassen A., Gao J., Ji P., Rampal R. K., Giles F. J., Tefferi A., Stein B. & Crispino J. D. (20190826). Aurora Kinase A Inhibition Provides Clinical Benefit, Normalizes Megakaryocytes, and Reduces Bone Marrow Fibrosis in Patients with Myelofibrosis: A Phase I Trial. : Clinical cancer research : an official journal of the American Association for Cancer Research.
Chicago
Gangat Naseema, Marinaccio Christian, Swords Ronan, Watts Justin M, Gurbuxani Sandeep, Rademaker Alfred, Fought Angela J, Frankfurt Olga, Altman Jessica K, Wen Qiang Jeremy, Farnoud Noushin, Famulare Christopher A, Patel Akshar, Tapia Roberto, Vallapureddy Rangit R, Barath Stephanie, Graf Amy, Handlogten Amy, Zblewski Darci, Patnaik Mrinal M, Al-Kali Aref, Dinh Yvonne Trang, Englund Prahl Kristen, Patel Shradha, Nobrega Juan Carlos, Tejera Dalissa, Thomassen Amber, Gao Juehua, Ji Peng, Rampal Raajit K, Giles Francis J, Tefferi Ayalew, Stein Brady and Crispino John D. 20190826. Aurora Kinase A Inhibition Provides Clinical Benefit, Normalizes Megakaryocytes, and Reduces Bone Marrow Fibrosis in Patients with Myelofibrosis: A Phase I Trial. : Clinical cancer research : an official journal of the American Association for Cancer Research.
Harvard
Gangat N., Marinaccio C., Swords R., Watts J. M., Gurbuxani S., Rademaker A., Fought A. J., Frankfurt O., Altman J. K., Wen Q. J., Farnoud N., Famulare C. A., Patel A., Tapia R., Vallapureddy R. R., Barath S., Graf A., Handlogten A., Zblewski D., Patnaik M. M., Al-Kali A., Dinh Y. T., Englund Prahl K., Patel S., Nobrega J. C., Tejera D., Thomassen A., Gao J., Ji P., Rampal R. K., Giles F. J., Tefferi A., Stein B. and Crispino J. D. (20190826). Aurora Kinase A Inhibition Provides Clinical Benefit, Normalizes Megakaryocytes, and Reduces Bone Marrow Fibrosis in Patients with Myelofibrosis: A Phase I Trial. : Clinical cancer research : an official journal of the American Association for Cancer Research.
MLA
Gangat Naseema, Marinaccio Christian, Swords Ronan, Watts Justin M, Gurbuxani Sandeep, Rademaker Alfred, Fought Angela J, Frankfurt Olga, Altman Jessica K, Wen Qiang Jeremy, Farnoud Noushin, Famulare Christopher A, Patel Akshar, Tapia Roberto, Vallapureddy Rangit R, Barath Stephanie, Graf Amy, Handlogten Amy, Zblewski Darci, Patnaik Mrinal M, Al-Kali Aref, Dinh Yvonne Trang, Englund Prahl Kristen, Patel Shradha, Nobrega Juan Carlos, Tejera Dalissa, Thomassen Amber, Gao Juehua, Ji Peng, Rampal Raajit K, Giles Francis J, Tefferi Ayalew, Stein Brady and Crispino John D. Aurora Kinase A Inhibition Provides Clinical Benefit, Normalizes Megakaryocytes, and Reduces Bone Marrow Fibrosis in Patients with Myelofibrosis: A Phase I Trial. : Clinical cancer research : an official journal of the American Association for Cancer Research. 20190826.